|
PSMB10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.0520999999849E-06 |
| Normal-vs-Stage3 |
1.8775999999221E-07 |
| Normal-vs-Stage4 |
4.237200E-03 |
| Stage1-vs-Stage2 |
6.806200E-01 |
| Stage1-vs-Stage3 |
8.592800E-01 |
| Stage1-vs-Stage4 |
5.345600E-02 |
| Stage2-vs-Stage3 |
7.826400E-01 |
| Stage2-vs-Stage4 |
2.378400E-01 |
| Stage3-vs-Stage4 |
1.796390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.85690018916773E-10 |
| Normal-vs-Asian |
1.244360E-02 |
| Caucasian-vs-AfricanAmerican |
8.497600E-01 |
| Caucasian-vs-Asian |
1.125780E-01 |
| AfricanAmerican-vs-Asian |
1.115230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
6.51570020160364E-10 |
| Male-vs-Female |
7.194300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.75360000356883E-08 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
4.22699999447218E-08 |
| Normal-vs-Extreme_Obese |
1.391550E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.090160E-02 |
| Normal_Weight-vs-Obese |
1.915200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.133600E-01 |
| Extreme_Weight-vs-Obese |
5.783800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.229220E-01 |
| Obese-vs-Extreme_Obese |
4.878200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.36630000000071E-05 |
| Normal-vs-Age(41-60Yrs) |
1.58761892521397E-14 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
1.144710E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.409200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.895000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.809600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.349200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.488950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.658420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.15239999992833E-07 |
| Normal-VS-KIRP CIMP |
2.616200E-02 |
| Normal-VS-Unclassified PRCC |
2.09721129351692E-13 |
| Type1 PRCC-VS-Type2 PRCC |
4.146600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.983800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.139400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.526800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.837020E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.844200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.48165940522449E-13 |
| Normal-vs-N1 |
5.58509999999401E-05 |
| Normal-vs-N2 |
1.588810E-01 |
| N0-vs-N1 |
8.074600E-01 |
| N0-vs-N2 |
4.071600E-02 |
| N1-vs-N2 |
1.506000E-01 |
|
|
